Petco Health & Wellness Company, Inc. (WOOF) Form 8-K — Sep 2, 2026
Petco (Nasdaq: WOOF) reported Q2 2026 results on September 2, 2026, with net sales of $1.5 billion, up 0.05%, and comparable sales up 0.6% — its second consecutive quarter of positive comps. Net income rose to $38.7 million from $14.0 million a year earlier and adjusted EBITDA increased to $122.2 million from $113.9 million, delivering profitability ahead of the company's outlook. Results include a $6.8 million net benefit from substantially all IEEPA tariff refunds tied to tariffs paid in 2025 and 2026; excluding that benefit, normalized adjusted EBITDA was $115.4 million.
Key figures
- Eps
- 0.13
- Revenue
- 1489220000
- Guidance
- FY2026 reaffirmed: net sales flat to up 1.5% YoY; Adjusted EBITDA $415-430 million; net interest expense ~$122 million; capex ~$140 million; D&A ~$200 million; net store closures ~15-20. Q3 2026: net sales +0.4% to +1.0%; Adjusted EBITDA $100-103 million.
- Net Income
- 38660000
- Total Debt
- 1479907000
- Revenue Yoy
- +0.05%
- Cash Position
- 293498000
- Net Debt
- $1,186.4 million
- Store Count
- 1377
- Gross Margin
- 39.7% of net sales, +37 bps YoY
- Gross Profit
- $591.1 million
- Ytd Net Sales
- $2,986.0 million
- Ytd Net Income
- $23.5 million
- Adjusted EBITDA
- $122.2 million vs $113.9 million prior year
- Free Cash Flow YTD
- $60.8 million vs $9.9 million prior year
- Operating Income
- $47.8 million, +11.1% YoY
- Net Leverage Target
- 2x
- Prior Year Net Income
- $14.0 million
- Operating Cash Flow YTD
- $130.6 million vs $70.4 million prior year
- Comparable Sales Growth
- +0.6%
- Tariff Refund Net Benefit
- $6.8 million included in Q2 results
- Normalized Adjusted EBITDA
- $115.4 million excluding the tariff-refund net benefit
- Debt Prepayment Post Quarter
- $75.0 million
- Total Debt Prepayments Nine Months
- $170 million
Price after filing
Close on the filing date to close N calendar days later (from $2.58). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.